# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002402
Filing Date
2023-11-13
Accepted
2023-11-13 16:02:01
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | atxs-20230930x10q.htm iXBRL | 10-Q | 1867605
2 | EX-31.1 | atxs-20230930xex31d1.htm | EX-31.1 | 11348
3 | EX-31.2 | atxs-20230930xex31d2.htm | EX-31.2 | 11326
4 | EX-32.1 | atxs-20230930xex32d1.htm | EX-32.1 | 6201
| Complete submission text file | 0001410578-23-002402.txt |  | 6268449

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | atxs-20230930.xsd | EX-101.SCH | 37334
6 | EX-101.CAL | atxs-20230930_cal.xml | EX-101.CAL | 38766
7 | EX-101.DEF | atxs-20230930_def.xml | EX-101.DEF | 167290
8 | EX-101.LAB | atxs-20230930_lab.xml | EX-101.LAB | 375609
9 | EX-101.PRE | atxs-20230930_pre.xml | EX-101.PRE | 257181
51 | EXTRACTED XBRL INSTANCE DOCUMENT | atxs-20230930x10q_htm.xml | XML | 966803

Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 231398461
SIC: 2834 Pharmaceutical Preparations